Cutanos raises €1.8M Seed round

The funding will be used to further develop the company's Langerhans Cell Targeted Delivery System (LC-TDS) technology in the fields of viral vaccines and autoimmune diseases, as well as to demonstrate the platform's potential for transdermal drug delivery.

Source: https://www.lisavienna.at/news/details/lisavienna-takes-a-look-behind-the-scenes-khan-i-fund-actively-involved-in-setting-up-vienna-based-cutanos-gmbh/